UMPS and leukemia: AICAr shares the same mechanisms of action with well-known inhibitors of de novo pyrimidine synthesis that have been previously shown to induce uridine-dependent leukemia differentiation, such as DHODH inhibitors brequinar [10] and leflunomide [40], or UMP synthase inhibitor pyrazofurin [10].